Currently holds a position at WAVE Life Sciences Ltd
Position | Company | Period |
---|---|---|
Chief Medical Officer | WAVE Life Sciences Ltd | Nov. 1, 2018 - |
Franchise Lead, Neurology | WAVE Life Sciences Ltd | July 1, 2016 - Oct. 1, 2018 |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2022-05-06 | 2022-05-05 |
WAVE Life Sciences Ltd
(WVE)
|
PS Planned sale |
16,714
-13.3%
1.7228,748 USD |
16,714 -13.3% | 1.72 | 28,748 USD | |
2022-02-18 | 2022-02-16 |
WAVE Life Sciences Ltd
(WVE)
|
S Sale |
10,603
-12.3%
2.3124,493 USD |
10,603 -12.3% | 2.31 | 24,493 USD | |
2021-02-18 | 2021-02-16 |
WAVE Life Sciences Ltd
(WVE)
|
PS Planned sale |
2,929
-3.3%
10.5730,960 USD |
2,929 -3.3% | 10.57 | 30,960 USD | |
2020-02-20 | 2020-02-18 |
WAVE Life Sciences Ltd
(WVE)
|
PS Planned sale |
2,981
-7.0%
7.8523,401 USD |
2,981 -7.0% | 7.85 | 23,401 USD | |
2019-07-09 | 2019-07-05 |
WAVE Life Sciences Ltd
(WVE)
|
PS Planned sale |
445
-1.0%
27.2612,131 USD |
445 -1.0% | 27.26 | 12,131 USD | |
2019-07-09 | 2019-07-05 |
WAVE Life Sciences Ltd
(WVE)
|
PS Planned sale |
2,613
-5.8%
26.8870,237 USD |
2,613 -5.8% | 26.88 | 70,237 USD | |
2019-03-11 | 2019-03-11 |
WAVE Life Sciences Ltd
(WVE)
|
PS Planned sale |
7,000
-13.4%
48.00336,000 USD |
7,000 -13.4% | 48.00 | 336,000 USD | |
2019-02-21 | 2019-02-19 |
WAVE Life Sciences Ltd
(WVE)
|
PS Planned sale |
1,837
-4.7%
36.8467,674 USD |
1,837 -4.7% | 36.84 | 67,674 USD | |
2018-02-21 | 2018-02-16 |
WAVE Life Sciences Ltd
(WVE)
|
PS Planned sale |
511
-1.3%
52.1026,623 USD |
511 -1.3% | 52.10 | 26,623 USD | |
2017-07-13 | 2017-07-12 |
WAVE Life Sciences Ltd
(WVE)
|
PS Planned sale |
7,414
-32.6%
16.67123,620 USD |
7,414 -32.6% | 16.67 | 123,620 USD |